NAT2 polymorphisms associated with the development of hepatotoxicity after first-line tuberculosis treatment in Mexican patients: From genotype to molecular structure characterization-Reference-Cited by-同舟云学术

NAT2 polymorphisms associated with the development of hepatotoxicity after first-line tuberculosis treatment in Mexican patients: From genotype to molecular structure characterization

Published:2021-08 Issue: Volume:519 Page:153-162
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Herrera-Rodulfo Aldo^ORCID,Carrillo-Tripp Mauricio^ORCID,Laura Yeverino-Gutierrez Myrna,Peñuelas-Urquides Katia^ORCID,Adiene González-Escalante Laura,Bermúdez de León Mario,Silva-Ramirez Beatriz

Funder

Consejo Nacional de Ciencia y Tecnologia

Instituto Mexicano del Seguro Social

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Biochemistry,General Medicine

Reference39 articles.

1. Global tuberculosis report 2020. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.

2. The End TB Strategy, World Health Organization. (2017), (accessed March 7, 2021). https://www.who.int/tb/strategy/end-tb/en/.

3. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment;Awofeso;Bull. World Health Organ.,2008

4. Global Alliance for TB Drug Development, Handbook of Anti-Tuberculosis Agents. Tuberculosis (2008), 88 (2), pp. 112-116. https://www.sciencedirect.com/journal/tuberculosis/vol/88/issue/2 (accessed March 7, 2021).

5. Mechanism of isoniazid-induced hepatotoxicity: then and now;Metushi;Br. J. Clin. Pharmacol.,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variants in the N-Acetyltranferase 2 Gene, Acetylator Phenotypes and Association with Tuberculosis. Findings in Peruvian Patients;2024

2. Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles;International Journal of Molecular Sciences;2023-02-08

3. Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury;Molecular Biology Reports;2022-12-23

4. Homozygotes NAT2*5B slow acetylators are highly associated with hepatotoxicity induced by anti-tuberculosis drugs;Memórias do Instituto Oswaldo Cruz;2022

5. Drugs used in the treatment of tuberculosis and leprosy;Side Effects of Drugs Annual;2022